Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Clinical trial NCT02027064 · UNKNOWN
Trial details
- NCT number
- NCT02027064
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.